Literature DB >> 10433958

Thrombotic microangiopathy in the HIV-2-infected macaque.

F Eitner1, Y Cui, K L Hudkins, A Schmidt, T Birkebak, M B Agy, S L Hu, W R Morton, D M Anderson, C E Alpers.   

Abstract

Thrombotic microangiopathy (TMA) has been increasingly reported in human immunodeficiency virus (HIV)-infected humans over the past decade. The pathogenesis is unknown. We prospectively analyzed the renal pathology and function of 27 pigtailed macaques (Macaca nemestrina), infected intravenously with a virulent HIV-2 strain, HIV-2(287), in addition to that of four uninfected control macaques. Necropsies were performed between 12 hours and 28 days after infection. HIV-2 antigen was detectable in peripheral blood mononuclear cell (PBMC) cocultures in all animals after 10 days of HIV-2 infection; a rapid decline in CD4(+) PBMC (<350/microliter) was seen in five of six animals 21 days and 28 days after infection. No macaque developed features of clinical AIDS. Typical lesions of human HIV-associated nephropathy were undetectable. Six of the 27 HIV-2-infected macaques demonstrated both histological TMA lesions (thrombi in glomerular capillary loops and small arteries, mesangiolysis) and ultrastructural lesions (mesangiolysis, subendothelial lucency, platelet thrombi in glomerular capillary lumina). Extrarenal thrombi were detected in the gastrointestinal and adrenal microvasculature of macaques that had developed renal TMA. None of the control animals demonstrated features of renal TMA at necropsy. In a retrospective analysis of kidneys obtained from 39 additional macaques infected with HIV-2(287), seven cases demonstrated TMA. In situ hybridization showed no detectable HIV-2 RNA in kidney sections of 65/66 HIV-2-infected macaques, including all 13 TMA cases. Expression of the chemokine receptor CXCR4, the putative coreceptor for HIV-2(287), was absent in intrinsic renal cells in all HIV-2-infected macaques. The HIV-2-infected macaque may be a useful model of human HIV-associated TMA. Our data do not support a role of direct HIV-2 infection of intrinsic renal cells as an underlying mechanism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10433958      PMCID: PMC1866875          DOI: 10.1016/S0002-9440(10)65161-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

Review 1.  Chemokine receptors and HIV.

Authors:  C C Broder; R G Collman
Journal:  J Leukoc Biol       Date:  1997-07       Impact factor: 4.962

Review 2.  Pathogenesis and treatment of thrombotic microangiopathy.

Authors:  P Ruggenenti; J Lutz; G Remuzzi
Journal:  Kidney Int Suppl       Date:  1997-03       Impact factor: 10.545

Review 3.  Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry.

Authors:  R W Doms; S C Peiper
Journal:  Virology       Date:  1997-09-01       Impact factor: 3.616

Review 4.  Human immunodeficiency virus infection and thrombotic microangiopathy.

Authors:  K B Hymes; S Karpatkin
Journal:  Semin Hematol       Date:  1997-04       Impact factor: 3.851

5.  Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1.

Authors:  F J Novembre; M Saucier; D C Anderson; S A Klumpp; S P O'Neil; C R Brown; C E Hart; P C Guenthner; R B Swenson; H M McClure
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

Review 6.  Renal complications in HIV disease.

Authors:  T K Rao
Journal:  Med Clin North Am       Date:  1996-11       Impact factor: 5.456

7.  Focal segmental glomerulosclerosis in primates infected with a simian immunodeficiency virus.

Authors:  C E Alpers; C C Tsai; K L Hudkins; Y Cui; L Kuller; R E Benveniste; J M Ward; W R Morton
Journal:  AIDS Res Hum Retroviruses       Date:  1997-03-20       Impact factor: 2.205

8.  Thrombotic microangiopathy and cytomegalovirus disease in patients infected with human immunodeficiency virus.

Authors:  C Maslo; M N Peraldi; J C Desenclos; B Mougenot; C Cywiner-Golenzer; F P Chatelet; C Jacomet; E Rondeau; W Rozenbaum; J D Sraer
Journal:  Clin Infect Dis       Date:  1997-03       Impact factor: 9.079

9.  CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry.

Authors:  J D Reeves; A McKnight; S Potempa; G Simmons; P W Gray; C A Power; T Wells; R A Weiss; S J Talbot
Journal:  Virology       Date:  1997-04-28       Impact factor: 3.616

10.  CD4-independent infection by HIV-2 is mediated by fusin/CXCR4.

Authors:  M J Endres; P R Clapham; M Marsh; M Ahuja; J D Turner; A McKnight; J F Thomas; B Stoebenau-Haggarty; S Choe; P J Vance; T N Wells; C A Power; S S Sutterwala; R W Doms; N R Landau; J A Hoxie
Journal:  Cell       Date:  1996-11-15       Impact factor: 41.582

View more
  6 in total

1.  Rapid shift from virally infected cells to germinal center-retained virus after HIV-2 infection of macaques.

Authors:  F Eitner; Y Cui; G Grouard-Vogel; K L Hudkins; A Schmidt; T Birkebak; M B Agy; S L Hu; W R Morton; D M Anderson; E A Clark; C E Alpers
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

2.  Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates.

Authors:  Ivona Pandrea; Elaine Cornell; Cara Wilson; Ruy M Ribeiro; Dongzhu Ma; Jan Kristoff; Cuiling Xu; George S Haret-Richter; Anita Trichel; Cristian Apetrei; Alan Landay; Russell Tracy
Journal:  Blood       Date:  2012-05-31       Impact factor: 22.113

3.  Sulfated glycosphingolipid as mediator of phagocytosis: SM4s enhances apoptotic cell clearance and modulates macrophage activity.

Authors:  Zoran V Popovic; Roger Sandhoff; Tjeerd P Sijmonsma; Sylvia Kaden; Richard Jennemann; Eva Kiss; Edgar Tone; Frank Autschbach; Nick Platt; Ernst Malle; Hermann-Josef Gröne
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

4.  HIV and SIV Associated Thrombocytopenia: An Expanding Role for Platelets in the Pathogenesis of HIV.

Authors:  Kelly A Metcalf Pate; Joseph L Mankowski
Journal:  Drug Discov Today Dis Mech       Date:  2011-11-09

Review 5.  Using the pathogenic and nonpathogenic nonhuman primate model for studying non-AIDS comorbidities.

Authors:  Ivona Pandrea; Alan Landay; Cara Wilson; Jennifer Stock; Russell Tracy; Cristian Apetrei
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

6.  Antibiotic and Antiinflammatory Therapy Transiently Reduces Inflammation and Hypercoagulation in Acutely SIV-Infected Pigtailed Macaques.

Authors:  Ivona Pandrea; Cuiling Xu; Jennifer L Stock; Daniel N Frank; Dongzhu Ma; Benjamin B Policicchio; Tianyu He; Jan Kristoff; Elaine Cornell; George S Haret-Richter; Anita Trichel; Ruy M Ribeiro; Russell Tracy; Cara Wilson; Alan L Landay; Cristian Apetrei
Journal:  PLoS Pathog       Date:  2016-01-14       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.